A Virginia Tech scientist emphasizes the importance of preserving the nation's ability to turn discovery into life-saving therapies. He argues that strong transparency and careful oversight are key to making the technology-transfer ecosystem work, and that abandoning it could have unintended consequences.
The Vilcek Foundation has awarded $9.6 million to 14 individuals from 12 countries for their contributions to the arts and sciences in the US. This year's prize winners include scientists, artists, and fashion designers who have made significant advancements in their fields.
Dr. Candida Rebello's five-year NIH grant will explore lifestyle strategies to reduce excess body fat and declining muscle mass in older adults with obesity. The study aims to protect skeletal muscle health, independence, and quality of life for this rapidly growing population.
The new NIH policy on research using human fetal tissue could undermine the development of life-saving therapies for various diseases. The ISSCR urges NIH to reconsider its decision and engage constructively with the scientific community to support biomedical research.
A study analyzing millions of biomedical and life science articles reveals that female-authored articles spend longer under review than comparable male-authored articles across most fields. The disparity underscores the ongoing issue of women's underrepresentation in academia, particularly in STEMM fields.
BioPathNet is an AI method that analyzes large biomedical knowledge graphs to identify hidden connections between genes, diseases, and drugs. The model proposes hypotheses that can be tested experimentally or clinically, providing a hypothesis-generating tool for researchers.
The DASH Diet, developed at Pennington Biomedical Research Center, has been ranked as the best heart-healthy diet and second-best overall by US News & World Report. The diet's focus on fiber, heart-healthy minerals, and whole grains helps lower blood pressure and reduce cardiovascular risk.
Pennington Biomedical researchers investigated competing body weight regulation models, analyzing the interaction of energy intake and expenditure. The study highlights the need to test state-of-the-art technology and could help explain why losing weight is challenging for some individuals.
Dr. Gang Hu, a leading expert in chronic disease epidemiology, has been appointed to the NIH Reproductive, Perinatal and Pediatric Health Review Group. He will evaluate studies on reproductive, perinatal, and pediatric health, with a focus on lifestyle factors and their impact on chronic diseases.
Dr. Jennifer Rood, Associate Executive Director for Cores and Resources, takes on interim leadership role at Pennington Biomedical Research Center while an international search for the next full-time Executive Director is underway. She brings over 30 years of experience in obesity and chronic disease research.
Jason McCarthy, a renowned biomedical researcher, has been promoted to professor at the Masonic Medical Research Institute. He has made significant contributions to medical research since joining the organization in 2018.
Philip R. Troyk, director of the Pritzker Institute of Biomedical Science and Engineering at Illinois Tech, has been elected as a Fellow of the National Academy of Inventors for his groundbreaking work on neuroprosthetic devices, including an implanted cortical visual prosthesis that provides artificial vision to individuals with profo...
A study analyzing 1000 biomedical articles found that almost 1 in 5 'recent' references are at least 10 years old, suggesting the term is used more as a narrative device than a measure of time. Citation patterns varied across medical specialties, with some fields citing older references than others.
Pennington Biomedical Research Center launched its first international scientific symposium in Riyadh, Saudi Arabia, exceeding expectations with distinguished audience engagement and new institutional contacts.
The Pew Charitable Trusts has funded seven new biomedical research collaborations, bringing together 14 renowned scientists to tackle pressing problems in human health. These interdisciplinary projects will accelerate discoveries and advance understanding of human biology and disease.
Researchers at Virginia Tech's Fralin Biomedical Research Institute are developing tools to gather high-quality brain function data during infancy, enabling studies on brain development and potential risk factors for disorders. The study aims to capture real-time brain activity during natural social interactions.
Dr. Corby Martin has been appointed as the Associate Executive Director for Scientific Education at Pennington Biomedical Research Center. He will provide leadership for key programs such as the T32 Postdoctoral Training Program, the Pennington Scientific Symposium and the Bray Obesity Symposium.
A recent study published in Obesity found a direct relationship between obesity severity and the likelihood of disease burden in the US population. The researchers discovered that higher BMI levels were associated with increased odds for various cardiometabolic conditions, including diabetes, hypertension, and kidney disease.
Dr. Leanne Redman joins the Charles Perkins Centre to lead research on obesity, diet, and exercise, building on her extensive experience in women's health issues and translational research. With over 300 publications and numerous awards, she will expand the centre's impact on global health.
Cynthia Nau Cornelissen has received nearly $7 million in federal grants to combat sexually transmitted infections (STIs), particularly gonorrhea. The researcher will study the human-specific pathogen Neisseria gonorrhoeae and develop vaccines and therapeutics using innovative approaches.
Researchers Andrew Gewirtz and Lanying Du from the Institute for Biomedical Sciences at Georgia State University have been recognized as Highly Cited Researchers in 2025. They are among the top 1% of globally impactful researchers, with highly cited papers in multiple fields.
Four researchers from LSU's Pennington Biomedical Research Center have been named among the world's most highly cited scientists. Dr. Steven Heymsfield, Dr. Peter Katzmarzyk, Dr. Eric Ravussin and Dr. Donna Ryan are recognized for their significant and broad influence in their respective fields.
A new gene editing technique, P3a mutagenesis, achieves near 100% success in creating precise DNA mutations. This method simplifies protein engineering, accelerating biomedical research and reducing costs.
Pennington Biomedical researchers will participate in numerous panels and presentations during the conference, sharing their latest findings on obesity treatment and prevention. The institution is well-represented at the event, with faculty members among the experts leading courses, presentations, and speaker panels.
The National Institutes of Health has renewed Pennington Biomedical's Metabolic Basis of Disease Center for five years, providing $2.2M per year to support research on the mechanisms of metabolic health. The center aims to address the obesity epidemic and its related illnesses.
The acquisition unifies genetics and stem cell research expertise to accelerate discovery and translate science into therapies. Researchers will gain access to advanced platforms, including the NYSCF Global Stem Cell Array, to study disease mechanisms and test treatments.
Christopher Chen, a renowned biomedical engineer, has been elected to the National Academy of Medicine for his groundbreaking contributions to cell and tissue engineering. His research may lead to lifesaving new treatments for disease, including heart attack cures and organ repairs.
Researchers at Binghamton University created a new technique for engineering vascular systems using nanotubes, which improved blood distribution and supplied cells with nutrition and oxygen. The technology has potential applications in treating tumors or neurodegenerative diseases.
The four-day training program equipped postdoctoral fellows with state-of-the-art methods for clinical research in obesity, metabolism and nutrition. Participants deepened their skills in gold-standard methodologies crucial for advancing clinical and translational research.
The bregr R package streamlines the process of analyzing large-scale biomedical data by automating model fitting, extracting tidy results, and providing publication-quality visualizations. This results in enhanced efficiency and scalability for researchers, while maintaining reproducibility and accuracy.
Professor Lim Chwee Teck, Director of NUS iHealthtech, has been elected an International Fellow of the Royal Academy of Engineering for his pioneering research in biomedical engineering and wearable technologies. His work on disease diagnosis and therapy has translated into impactful healthcare solutions through start-ups.
The 2025 Childhood Obesity Conference, hosted by Pennington Biomedical's Greaux Health initiative, aims to educate healthcare providers and promote healthier futures for Louisiana's children through cutting-edge research and evidence-based strategies. Participants can earn up to 7.5 CMEs and gain practical tools to support healthier fu...
Dr. Steven B. Heymsfield joins an elite group of scholars recognized for advancing knowledge and transforming their fields. He has authored over 1,300 scientific publications with nearly 79,000 citations, placing him among the top 500 most-cited researchers globally.
The Korea University College of Medicine hosted the K-CLUB International Symposium to promote interdisciplinary collaboration and address global health challenges. Distinguished global scholars explored the future of human health from diverse perspectives, including clinical care, biomedical convergence, and health policy.
Dr. Michael J. Welsh has advanced understanding and treatment of cystic fibrosis through his pioneering research on chloride channels and CFTR function. He has developed new therapies, including a porcine model of CF, leading to improved treatments for 90% of people with the disease.
A recent study by Pennington Biomedical researchers found that pregnant women with metabolically unhealthy obesity were twice as likely to develop gestational diabetes and had more body fat at birth. Despite lower weight gain, these mothers' metabolic health played a crucial role in their baby's development.
The Pennington Biomedical Research Center has opened a new Endocrinology and Diabetes Clinic in Baton Rouge, providing specialized care for patients managing diabetes and endocrine disorders. The clinic is led by Dr. Timothy Gilbert, who brings nearly 20 years of private practice experience to the region.
Researchers have discovered a way to selectively create links between sugar molecules, enabling precise control over the stereochemistry of oligosaccharides. This breakthrough could open up new avenues of biomedical research into these versatile molecules, providing access to previously difficult-to-construct oligosaccharides.
Dr. Nick Burton, a researcher at Van Andel Institute, has been awarded the Pew Charitable Trusts' prestigious Pew Scholar award in Biomedical Sciences. He will investigate how environmental factors influence health, including exposure to stress and microbes, and explore new Type 2 diabetes treatments.
The Pew Charitable Trusts has awarded four-year grants to 22 early-career scientists, enabling them to uncover fundamental insights about human health and disease. The selected researchers will explore various topics, including gut bacteria's role in metabolic diseases and the development of the human brain.
The Pew Charitable Trusts has funded 10 postdoctoral Latin American researchers for two years of biomedical science research in the US. They are exploring topics like brain tumor evolution, immune cell function, and nervous system repair.
Answer ALS is launching a groundbreaking collaboration with Tulane University and the Pennington Biomedical Research Center to harness AI for ALS treatment discovery. The Louisiana AI Drug Development Infrastructure for ALS (LADDIA) will prioritize therapeutic targets using AI-driven insights from the Answer ALS' Neuromine Data Portal.
Answer ALS has launched a groundbreaking collaborative initiative, LADDIA, to accelerate AI-powered drug discovery for ALS and other neurodegenerative diseases. The partnership aims to identify and prioritize therapeutic targets using AI-driven insights from the largest open-access ALS dataset.
The new microscope allows researchers to map and quantify the mechanical properties of biological tissues without interfering with them, enabling real-time monitoring. This breakthrough technology has far-reaching implications for fields such as inflammation, cancer, developmental biology, and biomedical materials.
The study highlights the challenges of commercializing renewable polymers, but also emphasizes the potential of chemical modification to improve their properties for clinical use. The research aims to provide a comprehensive overview of these sustainable materials in biomedical practice.
The Greaux Healthy initiative aims to prevent and treat childhood obesity through partnerships with healthcare providers, educators, and families. The program has developed tools and resources for four priority populations, including expectant families, preschool-aged children, school-aged children, and adolescents and young adults.
The June Small Shifts campaign focuses on incorporating more fruits and vegetables into daily meals and snacks, leading to energy, mood, and immune function improvements. By making simple changes, such as adding berries or carrot sticks, individuals can make a big impact on their overall health.
The Terasaki Institute and California State University, Northridge (CSUN) have launched a new collaboration initiative that brings advanced hands-on laboratory experience to CSUN Biology graduate students. Participating students will work alongside leading scientists on projects in various fields of biomedical research.
The BIAL Foundation is now accepting nominations for the 4th edition of its international award, recognizing exceptional work in biomedical research published within the last decade. Nominations are open until June 30, with a significant increase in prize amount to €350,000.
Four researchers — Carl June, Bruce Levine, Isabelle Rivière, and Michel Sadelain — are awarded the Merkin Prize for developing CAR T-cell therapy, a groundbreaking form of personalized cancer immunotherapy. The technology has led to durable remissions in tens of thousands of patients with previously incurable blood cancers.
Texas A&M University researchers have developed a customizable vessel-chip method that can mimic various blood vessel structures, enabling more accurate models of vascular disease. The chip technology enables patient-specific research and pharmaceutical testing, with the potential to cure vascular diseases.
New research from Binghamton University reveals that the topography patterns of wrinkled fingers remain constant after multiple immersions. The study found that blood vessels beneath the skin contract and move in relation to other vessels, resulting in consistent wrinkles.
Dr. Pasiakos joins Pennington Biomedical to lead research on muscle physiology, nutrition, neuroscience, and technology to optimize human performance in extreme conditions. His expertise strengthens capabilities for U.S. Military resilience, spaceflight bioenergetics, and elite athlete development.
The journal is inviting submissions on AI applications in biomedical engineering, focusing on medical device development, personalized diagnostics, and patient outcome prediction. Accepted articles will be published as part of a themed section showcasing current research on AI applications in biomedical engineering.
The American Association for the Advancement of Science (AAAS) CEO, Sudip S. Parikh, testified before the Senate Appropriations Committee about the importance of funding for biomedical research in America. He highlighted the risks of recent budget cuts and proposed budgets that could irreparably damage the nation's innovation ecosystem.
Researchers at Pennington Biomedical found that mitochondrial fragmentation can bypass defects in mitophagy to sustain skeletal muscle quality control in patients with Type 2 Diabetes. This adaptation helps maintain mitochondrial function despite impaired mitophagy.
Pennington Biomedical welcomes Dr. Adithya Hari, MD, with expertise in nuclear oncology and translational science, strengthening cancer research and patient-centered innovation in Louisiana. He will establish a research program focused on nuclear medicine and dedicate time to direct patient care through a clinical partnership.
Researchers at Pennington Biomedical Research Center investigated tirzepatide's effects on weight loss and metabolic health. The study found that tirzepatide decreased calorie intake and increased fat oxidation, leading to significant weight loss. However, the drug did not decrease the slowing down of metabolic rate usually observed wi...
The 2025 Bray Obesity Symposium provides valuable insights and guidance from leading researchers in obesity medicine. The symposium features topics such as advances in obesity genetics, pediatric obesity, lifestyle intervention, and pharmacotherapy.
The A*STAR Institute of Molecular and Cell Biology has achieved international recognition for research excellence while developing local scientific leaders. The institute's significant contributions include the discovery of protein kinases and phosphatases crucial to cell signalling, and the mapping of the fugu fish genome.